• +977-1-4003006/7
  • info@nitapolyclinic.com.np

Comprehensive Hereditary Cancer Gene Panel

Useful for assessing the risk of hereditary cancer. 

Details


Description

The test covers genes targeting hereditary cancers. The cancers covered are Breast, Ovarian, Uterine, Stomach, Endocrine Pancreas, Oesophagus, Colorectal, Endometrium, Ovarian, Bone, Thyroid, Kidneys, Urinary tract, Lung, Prostate, Central nervous system, Head & Neck, Liver, Cervix, Exocrine Pancreas, Small Intestine, Blood, Soft tissue, Skin, Peripheral nervous system & Endocrine glands.

 

Inclusive Gene

ABRAXAS1, AIP, ALK, APC, AR, ATM, AXIN2, BAP1, BARD1, BLM, BMPR1A, BRCA1, BRCA2, BRIP1, BUB1B, CBL, CDC73, CDH1, CDK4, CDKN1B, CDKN1C, CDKN2A, CHEK2, CTNNA1, CYLD, DDB2, DICER1, DIS3L2, ELAC2, EPCAM, ERCC2, ERCC3, ERCC4, ERCC5, EXT1, EXT2, FAN1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, FH, FLCN, GALNT12, GATA2, GPC3, HOXB13, HRAS, KIF1B, KIT, LZTR1, MAX, MEN1, MET, MITF, MLH1, MLH3, MRE11, MSH2, MSH3, MSH6, MSR1, MUTYH, NBN, NF1, NF2, NTHL1, PALB2, PAX5, PDGFRA, PHOX2B, PMS1, PMS2, POLD1, POLE, POT1, PRKAR1A, PRSS1, PTCH1, PTCH2, PTEN, RAD50, RAD51C, RAD51D, RB1, RECQL, RECQL4, RET, RHBDF2, RINT1, RNASEL, RNF43, RUNX1, SBDS, SDHA, SDHAF2, SDHB, SDHC, SDHD, SLC45A2, SLX4, SMAD4, SMARCB1, SMARCE1, SRGAP1, STK11, SUFU, TERT, TGFBR2, TMEM127, TP53, TSC1, TSC2, TYR, VHL, WRN, WT1, XPA, XPC, XRCC2, XRCC3, GREM2, SCG5


Test Code: MGM1841

Technique: Next Generation Sequencing (NGS)

Sample: 10 mL (8 mL min.) Whole blood in 1 Lavender Top (EDTA) tube. Ship immediately at 18–22°C.

Reported on: 35th working day by 7:00 p.m.

Precaution

Hereditary Cancer Risk Clinical Information is mandatory.

NRS. 41000 NRS. 42500

Available

Our Partners & Clients

chat